Royal Bank of Canada Purchases 6,774 Shares of Globe Life Inc. $GL

Royal Bank of Canada boosted its position in shares of Globe Life Inc. (NYSE:GL) by 3.8% during the first quarter, HoldingsChannel reports. The institutional investor owned 185,786 shares of the company’s stock after purchasing an additional 6,774 shares during the period. Royal Bank of Canada’s holdings in Globe Life were worth $25,855,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of GL. Compound Planning Inc. lifted its holdings in shares of Globe Life by 4.3% during the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock worth $275,000 after acquiring an additional 82 shares during the period. Root Financial Partners LLC increased its stake in Globe Life by 23.3% in the first quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock valued at $61,000 after acquiring an additional 83 shares during the last quarter. Transcend Capital Advisors LLC increased its stake in Globe Life by 3.9% in the fourth quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock valued at $317,000 after acquiring an additional 84 shares during the last quarter. Natural Investments LLC raised its position in Globe Life by 2.6% during the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after purchasing an additional 87 shares in the last quarter. Finally, Parallel Advisors LLC raised its position in Globe Life by 5.6% during the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after purchasing an additional 87 shares in the last quarter. 81.61% of the stock is owned by institutional investors.

Insider Buying and Selling at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 10,000 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $166.68, for a total value of $1,666,800.00. Following the completion of the transaction, the chief executive officer owned 54,020 shares of the company’s stock, valued at $9,004,053.60. This represents a 15.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Cheryl Alston sold 8,258 shares of the stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $179.24, for a total value of $1,480,163.92. Following the completion of the transaction, the director owned 16,621 shares of the company’s stock, valued at $2,979,148.04. This represents a 33.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 219,174 shares of company stock worth $37,675,349 over the last three months. 2.11% of the stock is owned by corporate insiders.

Globe Life Stock Performance

Shares of Globe Life stock opened at $184.08 on Wednesday. The company’s 50 day moving average price is $172.62 and its two-hundred day moving average price is $154.94. The firm has a market capitalization of $14.29 billion, a P/E ratio of 12.22 and a beta of 0.48. Globe Life Inc. has a fifty-two week low of $127.85 and a fifty-two week high of $191.55. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the company posted $3.05 earnings per share. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, equities analysts forecast that Globe Life Inc. will post 15.7 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have weighed in on GL. Jefferies Financial Group raised their target price on Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a report on Friday, July 10th. JPMorgan Chase & Co. boosted their price target on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a report on Tuesday, July 21st. Keefe, Bruyette & Woods reduced their price objective on Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a research note on Friday, July 24th. Weiss Ratings cut Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. Finally, TD Cowen boosted their target price on Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Globe Life has an average rating of “Moderate Buy” and an average price target of $191.67.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.